Endologix Price to Sales Ratio 2010-2020 | ELGXQ
Historical PS ratio values for Endologix (ELGXQ) over the last 10 years. The current P/S ratio for Endologix as of May 09, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Endologix P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2020-10-02 |
0.02 |
|
0.00 |
| 2020-06-30 |
0.80 |
$6.60 |
0.12 |
| 2020-03-31 |
0.69 |
$7.40 |
0.09 |
| 2019-12-31 |
1.58 |
$9.41 |
0.17 |
| 2019-09-30 |
3.97 |
$11.24 |
0.35 |
| 2019-06-30 |
7.24 |
$13.45 |
0.54 |
| 2019-03-31 |
6.61 |
$16.75 |
0.39 |
| 2018-12-31 |
0.72 |
$18.37 |
0.04 |
| 2018-09-30 |
1.91 |
$19.71 |
0.10 |
| 2018-06-30 |
5.66 |
$21.14 |
0.27 |
| 2018-03-31 |
4.23 |
$21.67 |
0.20 |
| 2017-12-31 |
5.35 |
$21.76 |
0.25 |
| 2017-09-30 |
4.46 |
$22.34 |
0.20 |
| 2017-06-30 |
4.86 |
$23.15 |
0.21 |
| 2017-03-31 |
7.24 |
$23.53 |
0.31 |
| 2016-12-31 |
5.72 |
$23.92 |
0.24 |
| 2016-09-30 |
12.80 |
$23.86 |
0.54 |
| 2016-06-30 |
12.46 |
$23.17 |
0.54 |
| 2016-03-31 |
8.36 |
$22.80 |
0.37 |
| 2015-12-31 |
9.90 |
$22.73 |
0.44 |
| 2015-09-30 |
12.26 |
$22.88 |
0.54 |
| 2015-06-30 |
15.34 |
$22.92 |
0.67 |
| 2015-03-31 |
17.07 |
$23.19 |
0.74 |
| 2014-12-31 |
15.29 |
$22.78 |
0.67 |
| 2014-09-30 |
10.60 |
$22.45 |
0.47 |
| 2014-06-30 |
15.21 |
$22.08 |
0.69 |
| 2014-03-31 |
12.87 |
$21.16 |
0.61 |
| 2013-12-31 |
17.44 |
$20.91 |
0.83 |
| 2013-09-30 |
16.14 |
$20.16 |
0.80 |
| 2013-06-30 |
13.28 |
$19.21 |
0.69 |
| 2013-03-31 |
16.15 |
$18.37 |
0.88 |
| 2012-12-31 |
14.24 |
$17.84 |
0.80 |
| 2012-09-30 |
13.82 |
$17.09 |
0.81 |
| 2012-06-30 |
15.44 |
$16.65 |
0.93 |
| 2012-03-31 |
14.65 |
$15.71 |
0.93 |
| 2011-12-31 |
11.48 |
$14.78 |
0.78 |
| 2011-09-30 |
10.04 |
$14.45 |
0.69 |
| 2011-06-30 |
9.30 |
$14.20 |
0.66 |
| 2011-03-31 |
6.78 |
$14.02 |
0.48 |
| 2010-12-31 |
7.15 |
$13.72 |
0.52 |
| 2010-09-30 |
4.56 |
$12.94 |
0.35 |
| 2010-06-30 |
4.53 |
$12.26 |
0.37 |
| 2010-03-31 |
4.04 |
$12.06 |
0.34 |
| 2009-12-31 |
5.28 |
$11.77 |
0.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.000B |
$0.000B |
|
Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis.
|
